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Abstract
This study sought to understand the relationship between child health outcomes 
and health spending while investigating lagged effects. The study employed 
panel data from 45 Sub-Saharan African countries between 1995 and 2011 
obtained from the World Bank’s World Development Indicators. Fixed and 
Random effect models were estimated. Under-five, infant and neonatal 
mortality were used as child health outcomes while total health spending was 
disaggregated into public and private spending. The effects of one and two 
period lags of expenditure were estimated. The results show a positive and 
significant relationship between health expenditure and child health outcomes 
with elasticities of -0.11 for infant mortality, -0.15 (under-five mortality) and 
-0.08 (neonatal mortality). Public health expenditure was found to be relatively 
more significant than private expenditure. Positive and significant lagged effects 
were also estimated between health expenditure and child health. The findings 
suggest that, while health expenditure is crucial for the improvement of child 
health, it is equally important for this expenditure to be sustainable as it also has 
delayed effects.     
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1. Introduction
Economic theory has over the years identified human capital as a catalyst to 
economic growth and development at the macro and micro levels (Wilson 
and Briscoe, 2004, Becker, 1964). Specifically, health capital development 
contributes to growth through increase in healthy time for both market and non-
market activities (Grossman, 1972, Muurinen, 1982). Improving health capital, 
therefore, remains principal on the development agenda of several governments 
over the world. 
In spite of this, adequate and sustained levels of health resources needed to 
develop health capital in Sub-Saharan Africa (SSA) are largely limited (Tandon 
and Cashin, 2010). The Abuja Declaration of 2001 was intended to improve 
public expenditure on health in SSA with the aim of improving population 
health. However, very few countries in the region are close to the target of 15 
percent of government budget (Tandon and Cashin, 2010). In 2011, exactly ten 
years after the declaration, only six countries had achieved this target. These 
countries include Rwanda (23 percent), Liberia (18.9 percent), Malawi (18.5 
percent), Madagascar (15.5 percent), Togo (15.4 percent) and Zambia (16.0 
percent) (World Bank, 2012).
Further, per capita expenditure on health is lowest in the SSA region, relative 
to all other regions of the world. Per capita expenditure on health in the region 
increased from US$ 79.4 in 2000 to US$ 154.6 in 2011. This was significantly 
less than the world average of US$ 1026.5 in 2011. Also, health financing in the 
SSA region are mostly from private sources and largely made up of catastrophic 
out of pocket (OOP) expenditure. The WHO estimates that up to 10 percent of 
the population in these countries suffer this type of financial catastrophe each 
year, with up to 4 percent pushed down the poverty line (WHO, 2012).  Similarly, 
other health related inputs in the SSA region have continually performed poorly 
over the years relative to other regions of the world. For instance, physician, 
nurse/midwife and dentistry density per 10,000 population was estimated to be 
2.2, 9.0 and 0.4, respectively in 2010, relative to the world average of 14.2, 28.1 
and 2.2, respectively (WHO, 2012).
Population health status in SSA also requires substantial improvements to 
meet set targets such as the Millennium Development Goals (MDGs), especially 
among children. Countries in the region continue to face high disease burdens 
and poor performance in terms of child health outcomes. It is reported that the 
Africa region lags behind in achieving the child health-related MDG targets 
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with most countries in the region unlikely to achieve these targets. The WHO 
(2012) also showed that only eight countries were on track to achieve the health 
related MDGs. Majority of the countries in the region were achieving less than 
50percent of what is expected to reach the target in 2015.
In light of the afore discussions, recent empirical studies (Martin et al. 
2011, Husain, 2010, Farage et al., 2012) have attempted to identify the exact 
relationship that exist between increased health expenditure and health outcomes. 
Not only have the findings of these studies been inconclusive1 but also neglected 
the possible lagged effects that may exist in this relationship. In this regard, this 
study sought to examine the relationship between health expenditure and health 
outcomes (with particular emphasis on child health outcomes) and examine the 
lagged effects of health expenditure on child health outcomes.
It was found that health expenditure significantly determines child health 
outcomes measured by infant, under five and neonatal mortality rates. These 
findings corroborate existing theoretical and empirical studies. It was also found 
that child health outcomes relate positively and statistically significant with the 
lags of health expenditure. This implies that health expenditure has a delayed 
effect on child health outcomes.  
The rest of the paper proceeds as follows; section two presents a brief review 
of the literature. Section three presents methods including data used in the 
analysis while section four presents the results. In section five, the results are 
discussed with various policy implications. The summary and conclusions are 
briefly presented in section six.
2. Literature review
Empirical analyses around macro level health expenditure have focused on 
three broad themes over the years. Some studies analysed the effects of per 
capita income on health expenditure (Baltagi and Mascone, 2010, Martin et al., 
2011, Jack and Lewis, 2009, Murthy and Okunade, 2009, Jaunky and Khadaroo, 
2008, Husain, 2010, Farag et al., 2012). Another group of studies has focused on 
estimating the relationship between health expenditure and aggregate population 
health (Babazono and Hillman, 1994, Berger and Messer, 2002, Bokhari et al., 
2007, Lawanson, 2012). A final set of studies in recent years has concentrated 
on the relationship between health aid and health outcomes at the macro level 
(Mallaye and Yogo, 2012, Mukherjee and Kizhakethalackal, 2012, Williamson, 
2008, Wilson et al., 2009).
1 Further discussion of this is presented in the literature review section of the paper.
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With regards to the focus of the current study, the last two sets of empirical 
studies were reviewed. Consequently, the review suggested that there exists a 
plethora of studies that estimate the relationship between health care expenditure 
and health outcomes at the macro level in developed regions with little attention 
on developing regions. Studies that have focused on developing regions with 
emphasis on SSA include Lawanson (2012), Anyanwu and Erhijakpor (2009), 
Akinkugbe and Mohanoe (2009) and Kamiya (2010) with all of these studies 
focusing on public health care expenditure and population health, including 
child health.
In general, there seem to be some level of inconsistency in the exact relationship 
that exist between health care expenditure and health outcomes. Some studies 
have shown that public health expenditure has no impact on health outcomes. 
For instance, Kamiya (2010) found that government spending on health do not 
lead to reduction in mortality in developing countries. Also, Filmer and Pritchett 
(1999) found that the most important determinant of child mortality outcomes 
was not public spending on health. Musgrove (1996) concluded that health 
care expenditure has no significant influence on child mortality. Much recently, 
in terms of health aid and health outcomes, Mukherjee and Kizhakethalackal 
(2012), Wilson et al. (2009) and Williamson (2008) all showed in their empirical 
studies that the relationship between health aid and reducing infant mortality 
rate was not significant.
In contrast, studies such as, Bokhari et al. (2007), Gupta et al. (2002) and 
Cremieux et al. (1999) found strong positive relationships between health 
spending and childhood mortality. Other studies like, Lawanson (2012), 
Anyanwu and Erhijakpor (2009) Murthy and Okunade (2009) have all 
established that public health expenditure significantly improves life expectancy, 
reduces under five mortality and infant mortality rates. Other studies that found 
positive relationship between health aid and health outcomes include Mallaye 
and Yogo (2012) and Mishra and Newhouse (2009) for the case of SSA. For 
instance, in the case of SSA, Lawanson (2012) estimated the effects of public 
health expenditure on health outcomes, measured by infant mortality, under-
five mortality, crude death rate and life expectancy. Using panel data between 
2003 and 2007 across 45 SSA countries with two-stage least squares and 
fixed effects estimates, the results showed that the relationship between public 
health expenditures and health outcomes was negative for mortality rates but 
positive for life expectancy. In an earlier study, Anyanwu and Erhijakpor (2007) 
examined the effectiveness of total and public health expenditure on two health 
outcome measures, namely under-five mortality and infant mortality rates across 
African countries. Their study employed panel data and two-stage ordinary 
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least squares estimation and found that both total health expenditure and per 
capita public health expenditure significantly influenced under-five and infant 
mortality rates in Africa. Their results showed that increasing per capita total 
health expenditure by 10 percent reduced under-five mortality by 21 percent and 
infant mortality by 22 percent while a 10 percent increase in per capita public 
health expenditure reduced under-five and infant mortality by 25 percent and 
21 percent, respectively. Using time series data from Lesotho, Akinkugbe and 
Mohanoe (2009) employed an error correction model (ECM) and found that in 
addition to public health care expenditure, the availability of physicians, female 
literacy and child immunization significantly influenced health outcomes. 
Farag et al. (2013) provided a more recent empirical investigation into the 
relationship between country health spending and selected health outcomes, 
measured by infant and child mortality. Using data from 133 low and middle 
income countries for the years 1995, 2000, 2005 and 2006, the study showed 
a significant impact of health spending on reducing infant and under five 
mortality rates with elasticities from 0.13 to 0.33 for infant mortality and 0.15 
to 0.38 for under five mortality rates. The study also found that the level of 
good governance determined the magnitude of the impact of government health 
spending on infant and under five mortality rates for each country. Countries 
with higher levels of good governance showed higher impact of government 
health spending on health outcomes.
Rhee (2012) performed a single country analysis of the effects of health care 
expenditure on infant mortality rate and life expectancy at birth in Korea. The 
study used time series data from 1985 to 2010. The results of the study indicate 
that there exists a significant and positive relationship between health care 
expenditure and the two measures of health outcomes with elasticities ranging 
from 0.01 to 0.02. Using the number of physicians and number of hospital beds as 
health inputs, the results showed significant relationship with elasticities ranging 
from 0.04 to 0.13. Rhee (2012) concluded that health care expenditure tends to 
be effective in the long run while the number of physicians and hospital beds are 
effective in the short run due to the magnitude of variation in the elasticities of 
the two sets of inputs. Bokhari et al. (2007) estimated the relationship between 
health care expenditure, per capita income and health outcomes nexus using 
under five mortality and maternal mortality as health outcome measures. The 
study found elasticities for under five mortality ranging from -0.25 to -0.42 
and maternal mortality ranging from -0.42 to -0.52, with respect to health care 
expenditure. An interesting implication of the results however suggests that 
economic growth is a more important contributor to health outcomes relative to 
government health expenditure for developing countries.
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In a similar study for 15 European Union countries over the period 1980-
1995, Nixon and Ulmann (2006) applied fixed effects model to panel data to 
estimate the relationship between health care expenditure and two measures of 
health outcomes (infant mortality and life expectancy). The results showed that 
increase in health care expenditure significantly influence infant mortality but 
only marginally in relation to life expectancy. Using mortality rates per 1000 
population with data from 20 OECD countries from 1960 to 1992, Berger and 
Messer (2002) showed that health care expenditure have a significant negative 
relationship with mortality rates.  Cremieux et al. (2005) used gender specific 
infant mortality and gender specific life expectancy at birth and at age 65 as 
measures of health outcomes. Panel data analysis from Canadian provinces 
showed that both public and private drug spending were significant for all the 
health outcome measures. Cremieux (1999) also investigated the impact of 
total health care spending (including both public and private sources) on gender 
specific infant mortality and life expectancy at birth using panel data from 
Canadian provinces over the period of 1978-1992, the study showed that health 
expenditure was significant for all outcomes with elasticity of -0.4 and -0.6 for 
male and female infant mortality, respectively; 0.05 and 0.024 for male and 
female life expectancy, respectively. Babazono and Hillman (1994) estimated 
the relationship between health care spending and health outputs measured by 
perinatal mortality, infant mortality, life expectancy at birth for both males and 
females and life expectancy at 80 years. Using data from 21 OECD countries 
for 1988 and multiple linear regression with stepwise analysis, they found that 
only female life expectancy at birth was significantly affected by health care 
expenditure with elasticity of 0.38. Hiltiris and Possnett (1992) also employed 
panel data from 20 OECD countries between 1960 and 1987. The results show 
that health expenditure had a negative impact on mortality with elasticity of -0.08.
With regards to health aid and health outcomes, Mukherjee and 
Kizhakethalackel (2012) investigated the impact of health aid on infant mortality 
rate and examine the role of education in understanding this nexus. The authors 
also investigated this nexus by disaggregating health aid into infectious disease 
control and nutrition health aids. Using data from poor developing countries, the 
results showed that education always lowers infant mortality rate but the overall 
effect of health aid remains insignificant. In terms of disaggregated health aid, 
the study also found that total health aid and nutrition aid may lower infant 
mortality rate only after education exceeds a threshold level.   
An important gap in the literature is the fact that previous studies have ignored 
the possibility of lag effects in estimating this relationship. For instance, Gupta 
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and Verhoeven (2001) acknowledged that there could be lags between spending 
and its effects on outcomes, however, they failed to address this problem. The 
current study therefore contributes to existing studies by introducing lag effects 
in the estimation of the relationship between health spending and child health 
outcomes. Public and private differences in these relationships were also explored.
3. Methodology
3.1. Theoretical framework
The theoretical framework adopted in this study follows Fayissa and Gutena 
(2008) who developed a macro level health production function based on 
the Grossman (Grossman, 1972) model. Like Grossman (1972), Fayissa and 
Gutena (2008) treated social, economic and environmental factors as inputs in 
the health production system. At the micro level the theoretical formulation can 
be simply expressed as follows
Where H is health output and x is a vector of individual inputs to the health 
production function, F. The elements of the vector of inputs include nutrient 
intake, income, consumption of public goods, education, time devoted to health-
related procedures, initial health stock and the environment.
While the above model analyses health production at the individual level, 
the current study seeks to analyse health production at the level of the health 
sector as a whole. Without loss of theoretical ground, Fayissa and Gutena 
(2008) presented a macro level specification of equation (1) by representing the 
elements of the vector x by per capita variables and regrouped into sub-sectors 
of economic, social and environmental factors. This specification is shown in 
the expression in equation (2) below
Where h is aggregated child health outcome, Y is a vector of per capita economic 
variables, S is a vector of per capita social variables and V is a vector of per 
capita environmental factors. 
Equation (2) can be re-written in its scalar form as follows
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vl) = V and n, m and l are number of variables in each sub-group, respectively.
Assuming a Cobb-Douglas production technology relating the inputs and 
outputs, then equation (3) can be transformed as
Where αi, βj and γk are elasticities. The term Ω in equation (4) estimates the 
initial health stock and measures the health status that would have been observed 
if there was no depreciation in health or health improvement due to changes in 
social, economic and environmental factors used in the production process. In 
a similar way                                     estimates the percentage change in child 
health status due to socioeconomic and environmental factors.
Taking the logarithmic transformation of equation (4) and rearranging yields 
equation (5) below
Where i = 1,...,n; j = 1,....,m and k = 1,....,l
Equation (5) also corresponds to the additive logarithm health production 
function derived by Koc (2004). According to Fayissa and Gutena (2008), 
the economic inputs in the health production function may include the total 
health care expenditure per capita in a particular country. This can further be 
disaggregated into private and public components of health expenditure.
3.2. Empirical model
Following Baltagi (2008), the starting point for the estimation of the relationship 
between health expenditure and child health outcomes in a panel regression 
model is specified as follows;
Where i and t denote countries (cross section units) and time (time series 
dimension) respectively. α is a scalar, β is Kx1 vector and Xit is the itth observation 
on Kth explanatory variables. 
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Where j in each equation represents different child health outcome measures as 
dependent variable and n represents different population brackets in terms of 
the explanatory variables. All variables were transformed and used in natural 
logarithms. Equation (7), (8) and (9) estimates the effect of total, public and 
private health expenditure on health outcomes, respectively. This allows for an 
understanding of the separate effect of each of these variables on the health 
outcomes of a population. The variables in the equations are further described 
in Appendix 1. All data used in the study was obtained from the World Bank's 
World Development Indicators (WDI) over the period 2005-2011 for 45 SSA 
countries2. The choice of sample period was justified by data availability.
To estimate the equations above, the fixed and random effect panel data 
models were used. As is the case in most panel data analysis, there was the 
need to test for random effects or panel effects in the model. As suggested by 
Baltagi (2008), the Breuch-Pagan Lagrange Multiplier (LM) test was used to 
make a decision between random effects regression and simple OLS regression. 
Secondly, the Hausman’s specification test was employed to compare estimates 
from the random effects and the fixed effects models. Panel data analysis also 
raises the issue of heteroskedasticity when the regression disturbances are not 
with the same variances across time and cross sectional units. Robust standard 
errors were therefore computed to correct for the presence of heteroskedasticity 
as suggested by Baltagi (2008).
4. Results
4.1. Health care expenditure and infant mortality rate 
The regression results for the effects of disaggregated health care expenditure 
on infant mortality rate with lag effects are presented in Table 1. The overall 
performance of the various regression models suggests that the models are well 
behaved. This can be observed from the probability values of the Wald chi square 
test and F-test for the fixed and random effects models, respectively. The various 
R-square statistics are also generally acceptable. The Hausman specification 
test generally seems to confirm the fixed effects model over the random effects 
model (Table 2). Both models were, however, reported to allow for robustness. 
2  The countries were : Angola, Benin, Burkina Faso, Botswana, Burundi, Cameroon, Cape Verde, Central 
African Republic, Chad, Comoros, Congo Demographic Republic, Congo, Cote d’Ivoire, Equatorial Guin-
ea, Eritrea, Ethiopia, Gabon, Ghana, Guinea, Guinea Bissau, Kenya, Lesotho, Liberia, Madagascar, Mala-
wi, Mali, Mauritania, Mauritius, Mozambique, Namibia, Niger, Nigeria, Rwanda, South Africa, Sao Tome, 
Senegal, Seychelles, Sierra Leone, Sudan, Swaziland, Tanzania, The Gambia, Togo, Uganda and Zambia.
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Moreover, a close observation of the models suggests not much difference. The 
Wald chi-square test strongly confirms the presence of heteroskedasticity in 
the fixed effects models. Robust standard errors were, therefore, estimated and 
reported in all the models to ensure consistent standard errors and unbiased 
estimates. The Breusch-Pagan lagrangian multiplier test also showed support 
for the random effects model over OLS estimations (Table 2).
The estimation results presented in Table 1 suggest that health expenditure is 
an important determinant of infant mortality in SSA. Total health expenditure 
(THE) showed negative and significant (at 1 percent level) relationship with 
infant mortality rate. The estimated elasticity for this relationship suggests 
that infant mortality will be reduced by approximately 1.1 percent when THE 
increases by 10 percent. Similar results were reported in both the fixed and 
random effects models.
The one and two-period lags of THE included in the regressions also showed 
negative and statistically significant relationship with infant mortality rate. The 
relationship was significant at 10 percent for the one-period lag and 1 percent for 
the two-period lag. This relationship was observed for both fixed and random 
effects models. The estimated elasticities suggest that a 10 percent increase in 
THE one year back reduces current year infant mortality by 0.80 percent in the 
fixed effects model and 0.70 percent in the random effects model. Similarly, 
a 10 percent increase in THE two years earlier reduces infant mortality by 
approximately 1.4 percent and 1.3 percent in fixed and random effects models 
respectively.       
The effect of disaggregated health care expenditure on infant mortality shows 
that a 10 percent increase in public health spending reduces infant mortality rate 
by approximately 0.60 percent in both the fixed and random effects models with 
statistical significance at 1 percent level. The one-period lag of public health 
spending showed negative but insignificant relationship with infant mortality. 
A much significant relationship was portrayed by the two-period lag of public 
health spending (at 1 percent level of significance). The relationship was 
consistent in both the fixed and random effects models.
Education, real GDP per capita, sanitation, HIV prevalence were also found to 
be important factors influencing infant mortality. Improved education, real GDP 
per capita and sanitation are likely to reduce infant mortality while increased 
HIV prevalence is likely to increase infant mortality. The relationships were 
consistent in both models.
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4.2. Health care expenditure and under-five mortality 
The regression results for the effects of disaggregated health care expenditure 
on under-five mortality are reported in Table 3. The joint significance of the 
model is confirmed by the probability values of the Wald chi-square test and 
F-test statistics for the fixed and random effects models. The within, between 
and overall R-squared values for both models also suggests the models have fits 
that can be trusted. Again, as in the previous analysis, the Hausman chi-square 
specification tests presented in Table 4 shows that results from models 1 and 2 
are better with the fixed effects model while model 3 is better specified in the 
random effects model. Results from both fixed and random effects specifications 
were, however, reported for all models. The BPLM test for random effects also 
confirmed that, relative to the OLS analysis, there were panel effects and hence 
the random effect specification should be used.
The estimated results show that all the explanatory variables had expected 
signs. Also, a general observation suggests that there exists a strong 
relationship between health care expenditure and under-five mortality in 
SSA. The relationship between THE and under-five mortality was estimated 
to be negative and statistically significant at 5 percent level. The results 
indicate that a 10 percent rise in the level of THE is likely to reduce under-
five mortality with estimated elasticities of approximately 1.1 percent for the 
fixed and random effects models. The one-period lag of THE was negative and 
statistically significant at 5 percent level in both models. This indicate that THE 
in the previous year impacts on under-five mortality negatively. Public health 
spending showed strongly significant (at 1 percent level) influence on under-five 
mortality in both models. The negative sign with an estimated elasticity of about 
-0.09 suggest that a 10 percent increase in PuHE leads to a reduction in under-
five mortality by 0.90 percent. The one-period lag of PuHE showed a negative 
and significant relationship with under-five mortality with estimated elasticity 
of approximately -0.1. Unlike public health care spending, private health care 
spending did not show statistical significance, even though the expected sign 
was observed. Education showed negative relationship with under-five mortality 
at 1 percent significance level. HIV prevalence was positively associated with 
under-five mortality, even though the relationship was only significant in the 
random effects model. Access to improved sanitation facilities showed negative 
relationship with under-five mortality at 10percent significance level.
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Source: Author's computation
Notes: ***significant at 1%; **significant at 5%; *significant at 10%. Standard errors are reported in 
parenthesis. (1) is model with total health expenditure as percent of GDP. (2) is model with private health 
expenditure as percent of GDP. (3) is model with private health expenditure as percent of GDP.
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Notes: *** shows significance at 5%
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Notes: ***significant at 1%; **significant at 5%; *significant at 10%. Standard errors are reported in 
parenthesis. (1) is model with total health expenditure as percent of GDP. (2) is model with private health 
expenditure as percent of GDP. (3) is model with private health expenditure as percent of GDP.
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4.3. Health expenditure and neonatal mortality 
Table 5 shows regression results of the relationship between health care spending 
and neonatal mortality in SSA. Judging from the R-square values, the models 
exhibit acceptable goodness of fit. The joint significance of the model was also 
confirmed with a probability value less than 0.01.
Diagnostic tests performed on the regression models suggest that the random 
effects model is preferable, relative to the fixed effects models. This is evident 
from the insignificant Hausman chi-square tests reported in Table 6. The Breusch-
Pagan lagrangian multiplier test for random effects also provides highly significant 
evidence in support of the random effects model, relative to the OLS. The Wald 
test also, strongly, confirmed the presence of heteroskedasticity. To remedy the 
problem of heteroskedasticity, robust standard errors were estimated and reported. 
Similar to the findings presented earlier, health care spending was generally 
significant in influencing neonatal mortality. Total health spending showed 
negative and significant (at 1 percent level) impact on neonatal mortality with 
estimated elasticities of approximately -0.08 in both the fixed and random 
effects models.  The one-period lag of total health spending also exhibited a 
significant (at 5 percent level) impact on neonatal mortality. The relationship 
showed estimated elasticities of -0.07 in the fixed effects model and -0.08 in the 
random effects model.
The results also showed an expected negative relationship between private 
health care spending and neonatal mortality. This relationship was, however, 
not significant at the statistically acceptable levels in both the fixed and random 
effects models. The one-period lag of private health spending was also not 
significant even though it showed the expected negative sign. Contrary to this, 
public spending on health showed the expected negative sign and also significant 
at the 5percent level. The negative relationship with estimated elasticities of 
approximately -0.04 in both the fixed and random effects models suggest that 
a 10percent increase in PuHE is likely to reduce neonatal mortality by about 
0.4percent. The one-period lag of the variable showed significant negative 
relationship with neonatal mortality with estimated elasticities of about -0.04 
in both models.
Other control variables that showed statistical significance in influencing 
neonatal mortality include education and sanitation. Education showed negative 
and significant (at 1 percent level) relationship across all the models. Access to 
sanitation facilities also showed similar inverse relationship with the dependent 
variable even though the level of significance was inconsistent across the models.
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Notes: ***significant at 1%; **significant at 5%; *significant at 10%. Standard errors are reported in 
parenthesis. (1) is model with total health expenditure as percent of GDP. (2) is model with private health 
expenditure as percent of GDP. (3) is model with private health expenditure as percent of GDP. 
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Notes: *** shows significance at 1%, ** shows significance at 5%
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5. Discussion
The results suggest that, in general, health expenditure had significant and 
positive influence on child health outcomes in SSA. The relationship was 
consistent and significant for all the various model specifications employed in 
the analysis. Health spending was associated with reduced infant, neonatal and 
under five mortality rates. A disaggregation of health expenditure suggests that 
public health expenditure was significant determinant of child health outcomes, 
relative to private health expenditure. The results conform with some earlier 
studies on the relationship that health spending have significant positive impact 
on health outcomes (Lawanson, 2012, Anyanwu and Erhijakpor, 2009). This 
implies that further investment in the health system of countries in SSA is needed 
to improve population health, especially among children. While many countries 
in the region face significant resource limitations, it has been suggested that 
there could still be additional revenue generated if resources are well managed 
(Mclntyre and Meheus, 2014).   
Aside the direct effects of health spending on health outcomes in SSA, the 
findings also suggest that there are lagged effects in the relationship. The one and 
two period lags introduced in the models were mostly significant. This suggests 
that investments in health may not have immediate impact on health status but 
the impact may be delayed with some time dimensions. This also implies that 
investments in the health system should not be one-off but continuous if the 
general objective of improved child health outcomes is to be achieved.
It is worth noting that the policy recommendation to increase resources 
committed to the health sector has been on the agenda of governments and 
various international partners. In fact, some targets, such as the Abuja Declaration 
of 2001, have been set to fulfil this recommendation and a close assessment 
suggests that there is still the need for strong commitments. The slow pace of 
progress across SSA countries in achieving the now defunct MDGs on health 
provides enough justification for this policy recommendation. Most countries in 
the region are faced with major health system challenges including poor access 
to health care, significant inequalities in health service utilization, lack of health 
care infrastructure and workforce. A sure way to ameliorate this situation is for 
governments to increase health sector resources.
Up to this point, the discussions have focused on the state as the major actor 
in strengthening health systems across the SSA region. While this has been 
a popular view and considered to be a sustainable way to improve the health 
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sector, some recent views have argued for a change in focus. For instance, 
Obeng-Odoom (2012) argued that an alternative approach to tackling the 
health sector challenges in developing countries is to shift focus from the state 
spending directly in the health sector to reducing poverty and inequality. The 
author argued that most of the health sector impediments in developing countries 
are exogenous and are closely related to wide-spread poverty and inequality. 
Effective population health improving policies should therefore not only focus 
on investing into the health sector but also reducing poverty and bridging the 
gap between the rich and poor. 
The study was limited in a number of ways. First, unavailability of data limited 
the extent to which analysis could be performed in the study. While the available 
data was used to achieve the objectives of explaining health spending in SSA, 
a more holistic analysis required that health spending be disaggregated into 
specific components such as spending on treatment, prevention, health system 
capital inputs and health workforce. Access to such data was however difficult. 
Also, the short time dimension of the health expenditure variables used in the 
study posed some limitations to the analysis. Owing to the above limitation on 
the length of time series, the econometric analysis employed in the study were 
also limited largely due to loss of degrees of freedom. For instance, the number of 
lags included in the models to capture the delayed effects of health spending on 
health outcomes was limited. There is also the possibility of endogeneity arising 
between the dependent variable and health expenditure. This was, however, not 
tested or addressed in the current paper due to our inability to identify a good 
instrument for this purpose.   
Finally, the health outcome variables used in the analysis were limited to 
mortality indicators of population health status. A more encompassing analysis 
required variables that consider both mortality and morbidity (longevity) 
indicators. Examples of such variables include disability adjusted life years 
(DALYs) and health-adjusted life expectancy (HALE). Information on these 
variables were hardly available for SSA countries. Future studies may consider 
these limitations as channels for improvement.
6. Conclusion
The study sought to examine the relationship between health expenditure and child 
health outcomes in SSA. The lag effect of the relationship was also investigated. 
A panel sample of 45 countries over the period of 1995-2011 was employed 
in the analysis. The findings suggest that health expenditure (both public and 
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private) impacts positively on child health outcomes. Public expenditure was, 
however, identified to be more significant. Evidence of delayed effects was 
also established in the health expenditure – health outcome nexus. The findings 
suggest that while health expenditure is crucial for the improvement of child 
health, it is equally important for this expenditure to be sustainable as it also 
has delayed effects. Effective and sustainable health policies should also tackle 
poverty and inequality.
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Appendix 1: Variable description
Variables Description
Health status (HS) Represents child health outcome measures including, neonatal 
mortality, Infant mortality and under-5 mortality
Neonatal mortality rate
(NMR)
Number of deaths during the first 28 completed days of life 
per1000 live births in a given year 
Under-five mortality rate
(U5M)
The probability of a child born in a specific year or period 
dying before reaching the age of five
Infant mortality rate
(IMR)
The probability of a child born in a specific year or period 
dying before reaching the age of one
Total health expenditure
(THE)
Total health expenditure expressed as a percentage of gross 
domestic product (GDP). Covers spending on preventive and 
curative health services, family planning activities etc.
Public health expenditure
(PuHE)
Level of public spending on health expressed as percent of 
GDP. Includes spending from government budgets, external 
borrowing, grants and social health insurance funds
Private health
Expenditure (PrHE)
Level of private expenditure on health expressed as a 
percentage of GDP. Includes direct household (out-of-pocket) 
spending, private insurance, charitable donations and direct 
service payments by private corporations
Real GDP per capita 
(RGDPpc) (Y)
Real GDP per capita measured in constant 2005 international 
dollars
DPT Immunization (Imm)  Percentage of children ages 12-23 months who received DPT 
immunization before 12 months 
Education (Educ) Secondary school enrolment as percentage of gross school 
enrolment
Sanitation (S) Percentage of population using an improved sanitation facility
HIV prevalence rate (HIV) Estimated number of adults aged 15-49 years with HIV 
infection expressed as percent of total population in that age 
group
Urbanization (Urban) (U) Percentage of population living in areas classified as urban 
according to the criteria used by each country
Population aged 14 years
and below (Pop1)
Population age group below or equal to 14 years expressed as 
percentage of total population
Population 15-64 years
(Pop2)
Population age group between 15 and 64 years expressed as 
percentage of total population
Population 65 years
and above (Pop3)
Population age group above 65 years expressed as 
percentage of total population
Source: Author's compilation
